about
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety EvaluationATM Signaling PathwayEffects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours.Polymorphisms in the DNA repair gene ERCC2/XPD and breast cancer risk: a HapMap-based case-control study among Han Women in a Chinese less-developed areaLymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast CarcinomaImproving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.Altered expression of the WT1 wilms tumor suppressor gene in human breast cancerRING finger protein 31 promotes p53 degradation in breast cancer cells.The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients.DNA repair is activated in early stages of p53-induced apoptosis.Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study.Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.
P2860
Q24802378-023B141D-E0DA-4ADC-9C74-8FECD69B996DQ26860299-60302C38-DD0B-465A-A016-9BC32343D3F2Q30225510-7875D768-5E06-4B36-8A10-B644BC8E5046Q33605964-76E5E6B1-5937-4AA0-A0EA-1FA549679FB7Q33747354-451B6139-30BA-4913-8190-3087B493C29FQ34206213-327A293C-8CA1-4535-AEE8-2F4B111DDE98Q34284010-C2CC2176-A35B-4126-8E13-8BEF1C0ADE92Q35157568-08E12547-0960-4EF4-9411-2467C87EB577Q35504371-AC3E8A85-297D-4C53-864C-9503AECD96EFQ35869273-9CDF65BF-F958-4008-8A9E-FDB40FF470B6Q36302661-34DCBDFF-2B8B-471F-9773-0AA9C2FAAED4Q36804413-7BCD4125-C404-45DF-91F1-5D5D3EE2744AQ38003702-7E1F7C2B-FDC2-4339-9E33-CB2E18DAA945Q38645153-D8E93760-5E66-44BC-BF97-7E3D9F0EEE49Q40768679-B19A3014-9769-42EC-B521-87C8016B8EEEQ43892052-07D03431-789B-4F00-BD78-44FB9FBD1F6DQ44221870-DE56C241-168F-4009-A656-1687B7A71AF5
P2860
description
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
scientific journal article
@en
vedecký článok (publikovaný 1996/04/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/04/01)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована у квітні 1996
@uk
مقالة علمية (نشرت في أبريل 1996)
@ar
name
P53, apoptosis, and breast cancer
@ast
P53, apoptosis, and breast cancer
@en
P53, apoptosis, and breast cancer
@nl
type
label
P53, apoptosis, and breast cancer
@ast
P53, apoptosis, and breast cancer
@en
P53, apoptosis, and breast cancer
@nl
prefLabel
P53, apoptosis, and breast cancer
@ast
P53, apoptosis, and breast cancer
@en
P53, apoptosis, and breast cancer
@nl
P2860
P356
P1476
P53, apoptosis, and breast cancer
@en
P2093
D. M. Barnes
R. S. Camplejohn
P2860
P2888
P304
P356
10.1007/BF02013640
P577
1996-04-01T00:00:00Z